← Browse by Condition
Medical Condition

alcohol liver disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2

ClinicalMetric aggregates all active clinical trials for alcohol liver disease from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries. Trials are updated daily as new studies open, status changes, and enrollment targets are updated.

  • Recruiting trials — currently enrolling participants, with eligibility criteria
  • Phase 1–4 studies — from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary for every trial listing
NCT07009860 Phase 2
Recruiting

RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Enrollment
100 pts
Location
United States, Puert...
Sponsor
Altimmune, Inc.
View Trial →